Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 459

1.

Longitudinal associations between youth tobacco and substance use in waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) Study.

Silveira ML, Conway KP, Green VR, Kasza KA, Sargent JD, Borek N, Stanton CA, Cohn A, Hilmi N, Cummings KM, Niaura RS, Lambert EY, Brunette MF, Zandberg I, Tanski SE, Reissig CJ, Callahan-Lyon P, Slavit WI, Hyland AJ, Compton WM.

Drug Alcohol Depend. 2018 Jul 25;191:25-36. doi: 10.1016/j.drugalcdep.2018.06.018. [Epub ahead of print]

PMID:
30077053
2.

Another Article About E-Cigarettes: Why Should I Care?

Cummings KM, Morris PB, Benowitz NL.

J Am Heart Assoc. 2018 Jul 14;7(14). pii: e009944. doi: 10.1161/JAHA.118.009944. No abstract available.

3.

"Teachable Moment" Interventions in Lung Cancer: Why Action Matters.

Dresler C, Warren GW, Arenberg D, Yang P, Steliga MA, Cummings KM, Stone E, Jassem J.

J Thorac Oncol. 2018 May;13(5):603-605. doi: 10.1016/j.jtho.2018.02.020. No abstract available.

PMID:
29703537
4.

Transitions in electronic cigarette use among adults in the Population Assessment of Tobacco and Health (PATH) Study, Waves 1 and 2 (2013-2015).

Coleman B, Rostron B, Johnson SE, Persoskie A, Pearson J, Stanton C, Choi K, Anic G, Goniewicz ML, Cummings KM, Kasza KA, Silveira ML, Delnevo C, Niaura R, Abrams DB, Kimmel HL, Borek N, Compton WM, Hyland A.

Tob Control. 2018 Apr 25. pii: tobaccocontrol-2017-054174. doi: 10.1136/tobaccocontrol-2017-054174. [Epub ahead of print]

PMID:
29695458
5.

Reported exposure to E-cigarette advertising and promotion in different regulatory environments: Findings from the International Tobacco Control Four Country (ITC-4C) Survey.

Wadsworth E, McNeill A, Li L, Hammond D, Thrasher JF, Yong HH, Cummings KM, Fong GT, Hitchman SC.

Prev Med. 2018 Jul;112:130-137. doi: 10.1016/j.ypmed.2018.04.022. Epub 2018 Apr 17.

PMID:
29678615
6.

Situational and Demographic Factors in the Sudden Growth of Pall Mall, 2002-2014.

Sharma A, Fix BV, Delnevo CD, Cummings KM, O'Connor RJ.

Nicotine Tob Res. 2018 May 3;20(6):775-778. doi: 10.1093/ntr/ntx140.

PMID:
29590469
7.

E-Cigarette and COPD: Unreliable Conclusion About Health Risks.

Cummings KM, Polosa R.

J Gen Intern Med. 2018 Jun;33(6):784-785. doi: 10.1007/s11606-018-4396-8. No abstract available.

PMID:
29564607
8.

Behavioral Economic Purchase Tasks to Estimate Demand for Novel Nicotine/Tobacco Products and Prospectively Predict Future Use: Evidence from the Netherlands.

Heckman BW, Cummings KM, Nahas GJ, Willemsen MC, O'Connor RJ, Borland R, Hirsch AA, Bickel WK, Carpenter MJ.

Nicotine Tob Res. 2018 Mar 14. doi: 10.1093/ntr/nty042. [Epub ahead of print]

PMID:
29547973
9.

Do predictors of smoking relapse change as a function of duration of abstinence? Findings from the United States, Canada, United Kingdom and Australia.

Yong HH, Borland R, Cummings KM, Partos T.

Addiction. 2018 Jul;113(7):1295-1304. doi: 10.1111/add.14182. Epub 2018 Mar 2.

PMID:
29405520
10.

Effect of an Evidence-based Inpatient Tobacco Dependence Treatment Service on 30-, 90-, and 180-Day Hospital Readmission Rates.

Cartmell KB, Dooley M, Mueller M, Nahhas GJ, Dismuke CE, Warren GW, Talbot V, Cummings KM.

Med Care. 2018 Apr;56(4):358-363. doi: 10.1097/MLR.0000000000000884.

PMID:
29401186
11.

Cannabis Use, Lung Cancer, and Related Issues.

Jett J, Stone E, Warren G, Cummings KM.

J Thorac Oncol. 2018 Apr;13(4):480-487. doi: 10.1016/j.jtho.2017.12.013. Epub 2018 Jan 31. Review.

PMID:
29374567
12.

A Naturalistic, Randomized Pilot Trial of E-Cigarettes: Uptake, Exposure, and Behavioral Effects.

Carpenter MJ, Heckman BW, Wahlquist AE, Wagener TL, Goniewicz ML, Gray KM, Froeliger B, Cummings KM.

Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1795-1803. doi: 10.1158/1055-9965.EPI-17-0460. Epub 2017 Nov 10.

PMID:
29127080
13.

State Tobacco Policies as Predictors of Evidence-Based Cessation Method Usage: Results From a Large, Nationally Representative Dataset.

Dahne J, Wahlquist AE, Garrett-Mayer E, Heckman BW, Cummings KM, Carpenter MJ.

Nicotine Tob Res. 2017 Sep 16. doi: 10.1093/ntr/ntx192. [Epub ahead of print]

PMID:
29059345
14.

Adult interest in using a hypothetical modified risk tobacco product: findings from wave 1 of the Population Assessment of Tobacco and Health Study (2013-14).

Pearson JL, Johnson AL, Johnson SE, Stanton CA, Villanti AC, Niaura RS, Glasser AM, Wang B, Abrams DB, Cummings KM, Hyland A.

Addiction. 2018 Jan;113(1):113-124. doi: 10.1111/add.13952. Epub 2017 Sep 6.

PMID:
28734111
15.

Does Adding Information on Toxic Constituents to Cigarette Pack Warnings Increase Smokers' Perceptions About the Health Risks of Smoking? A Longitudinal Study in Australia, Canada, Mexico, and the United States.

Cho YJ, Thrasher JF, Swayampakala K, Lipkus I, Hammond D, Cummings KM, Borland R, Yong HH, Hardin JW.

Health Educ Behav. 2018 Feb;45(1):32-42. doi: 10.1177/1090198117709884. Epub 2017 Jul 17.

PMID:
28715260
16.

Tobacco Use Prevalence and Outcomes Among Perinatal Patients Assessed Through an "Opt-out" Cessation and Follow-Up Clinical Program.

Buchanan C, Nahhas GJ, Guille C, Cummings KM, Wheeler C, McClure EA.

Matern Child Health J. 2017 Sep;21(9):1790-1797. doi: 10.1007/s10995-017-2309-9.

17.

Indicators of dependence for different types of tobacco product users: Descriptive findings from Wave 1 (2013-2014) of the Population Assessment of Tobacco and Health (PATH) study.

Strong DR, Pearson J, Ehlke S, Kirchner T, Abrams D, Taylor K, Compton WM, Conway KP, Lambert E, Green VR, Hull LC, Evans SE, Cummings KM, Goniewicz M, Hyland A, Niaura R.

Drug Alcohol Depend. 2017 Sep 1;178:257-266. doi: 10.1016/j.drugalcdep.2017.05.010. Epub 2017 Jun 28.

PMID:
28675817
18.
19.

Scientific Advances in Thoracic Oncology 2016.

Soo RA, Stone ECA, Cummings KM, Jett JR, Field JK, Groen HJM, Mulshine JL, Yatabe Y, Bubendorf L, Dacic S, Rami-Porta R, Detterbeck FC, Lim E, Asamura H, Donington J, Wakelee HA, Wu YL, Higgins K, Senan S, Solomon B, Kim DW, Johnson M, Yang JCH, Sequist LV, Shaw AT, Ahn MJ, Costa DB, Patel JD, Horn L, Gettinger S, Peters S, Wynes MW, Faivre-Finn C, Rudin CM, Tsao A, Baas P, Kelly RJ, Leighl NB, Scagliotti GV, Gandara DR, Hirsch FR, Spigel DR.

J Thorac Oncol. 2017 Aug;12(8):1183-1209. doi: 10.1016/j.jtho.2017.05.019. Epub 2017 Jun 1. Review.

20.

A Good Idea May Not Be Good Enough: Stakeholder Buy In to QuitConnect, a National Smokers' Registry.

Macauda MM, Thrasher JF, Saul JE, Celestino P, Cummings KM, Strayer SM.

Am J Health Promot. 2018 Jun;32(5):1187-1195. doi: 10.1177/0890117117708841. Epub 2017 Jun 1.

PMID:
28569071
21.

Behavioral economic substitution between conventional cigarettes and e-cigarettes differs as a function of the frequency of e-cigarette use.

Snider SE, Cummings KM, Bickel WK.

Drug Alcohol Depend. 2017 Aug 1;177:14-22. doi: 10.1016/j.drugalcdep.2017.03.017. Epub 2017 May 19.

22.

Cigarette Filter Ventilation and its Relationship to Increasing Rates of Lung Adenocarcinoma.

Song MA, Benowitz NL, Berman M, Brasky TM, Cummings KM, Hatsukami DK, Marian C, O'Connor R, Rees VW, Woroszylo C, Shields PG.

J Natl Cancer Inst. 2017 Dec 1;109(12). doi: 10.1093/jnci/djx075. Review.

23.

Internalized smoking stigma in relation to quit intentions, quit attempts, and current e-cigarette use.

O'Connor RJ, Rees VW, Rivard C, Hatsukami DK, Cummings KM.

Subst Abus. 2017 Jul-Sep;38(3):330-336. doi: 10.1080/08897077.2017.1326999. Epub 2017 May 8.

PMID:
28481713
24.

Nicotine Metabolite Ratio (NMR) Prospectively Predicts Smoking Relapse: Longitudinal Findings From ITC Surveys in Five Countries.

Fix BV, O'Connor RJ, Benowitz N, Heckman BW, Cummings KM, Fong GT, Thrasher JF.

Nicotine Tob Res. 2017 Sep 1;19(9):1040-1047. doi: 10.1093/ntr/ntx083.

PMID:
28387850
25.

Does the Regulatory Environment for E-Cigarettes Influence the Effectiveness of E-Cigarettes for Smoking Cessation?: Longitudinal Findings From the ITC Four Country Survey.

Yong HH, Hitchman SC, Cummings KM, Borland R, Gravely SML, McNeill A, Fong GT.

Nicotine Tob Res. 2017 Nov 1;19(11):1268-1276. doi: 10.1093/ntr/ntx056.

26.

Effectiveness of Switching Smoking-Cessation Medications Following Relapse.

Heckman BW, Cummings KM, Kasza KA, Borland R, Burris JL, Fong GT, McNeill A, Carpenter MJ.

Am J Prev Med. 2017 Aug;53(2):e63-e70. doi: 10.1016/j.amepre.2017.01.038. Epub 2017 Mar 20.

27.

Flavored Tobacco Product Use in Youth and Adults: Findings From the First Wave of the PATH Study (2013-2014).

Villanti AC, Johnson AL, Ambrose BK, Cummings KM, Stanton CA, Rose SW, Feirman SP, Tworek C, Glasser AM, Pearson JL, Cohn AM, Conway KP, Niaura RS, Bansal-Travers M, Hyland A.

Am J Prev Med. 2017 Aug;53(2):139-151. doi: 10.1016/j.amepre.2017.01.026. Epub 2017 Mar 16.

28.

Selling smoking cessation.

Cummings KM, Carpenter MJ.

Lancet. 2017 Feb 25;389(10071):768-770. doi: 10.1016/S0140-6736(17)30125-3. Epub 2017 Jan 25. No abstract available.

29.

Tobacco-Product Use by Adults and Youths in the United States in 2013 and 2014.

Kasza KA, Ambrose BK, Conway KP, Borek N, Taylor K, Goniewicz ML, Cummings KM, Sharma E, Pearson JL, Green VR, Kaufman AR, Bansal-Travers M, Travers MJ, Kwan J, Tworek C, Cheng YC, Yang L, Pharris-Ciurej N, van Bemmel DM, Backinger CL, Compton WM, Hyland AJ.

N Engl J Med. 2017 Jan 26;376(4):342-353. doi: 10.1056/NEJMsa1607538. Erratum in: N Engl J Med. 2018 Feb 1;378(5):492.

30.

Developing Consistent and Transparent Models of E-cigarette Use: Reply to Glantz and Soneji et al.

Levy DT, Borland R, Fong GT, Villanti AC, Niaura R, Meza R, Holford TR, Cummings KM, Abrams DB.

Nicotine Tob Res. 2017 Feb;19(2):268-270. doi: 10.1093/ntr/ntw236. Epub 2016 Oct 6. No abstract available.

PMID:
28082477
31.

Perceptions of Snus Among US Adult Smokers Given Free Product.

Meier E, Burris JL, Wahlquist A, Garrett-Mayer E, Gray KM, Alberg AJ, Cummings KM, Carpenter MJ.

Nicotine Tob Res. 2017 Dec 13;20(1):22-29. doi: 10.1093/ntr/ntw392.

PMID:
28034999
32.

The need for a comprehensive framework.

Levy DT, Fong GT, Cummings KM, Borland R, Abrams DB, Villanti AC, Niaura R.

Addiction. 2017 Jan;112(1):22-24. doi: 10.1111/add.13600. No abstract available.

33.

Feasibility of Implementing a Hospital-Based "Opt-Out" Tobacco-Cessation Service.

Nahhas GJ, Wilson D, Talbot V, Cartmell KB, Warren GW, Toll BA, Carpenter MJ, Cummings KM.

Nicotine Tob Res. 2017 Aug 1;19(8):937-943. doi: 10.1093/ntr/ntw312.

PMID:
27928052
34.

Cross-country comparison of smokers' reasons for thinking about quitting over time: findings from the International Tobacco Control Four Country Survey (ITC-4C), 2002-2015.

Kasza KA, Hyland AJ, Borland R, McNeill A, Fong GT, Carpenter MJ, Partos T, Cummings KM.

Tob Control. 2017 Nov;26(6):641-648. doi: 10.1136/tobaccocontrol-2016-053299. Epub 2016 Oct 26.

PMID:
27798323
35.

The Application of a Decision-Theoretic Model to Estimate the Public Health Impact of Vaporized Nicotine Product Initiation in the United States.

Levy DT, Borland R, Villanti AC, Niaura R, Yuan Z, Zhang Y, Meza R, Holford TR, Fong GT, Cummings KM, Abrams DB.

Nicotine Tob Res. 2017 Feb;19(2):149-159. doi: 10.1093/ntr/ntw158. Epub 2016 Jul 14.

36.

A Pilot Randomized Crossover Trial of Electronic Cigarette Sampling Among Smokers.

Meier E, Wahlquist AE, Heckman BW, Cummings KM, Froeliger B, Carpenter MJ.

Nicotine Tob Res. 2017 Feb;19(2):176-182. doi: 10.1093/ntr/ntw157. Epub 2016 Aug 22.

37.

Application of the Smokeless Tobacco Expectancies Questionnaire to Snus.

Adkison SE, Bansal-Travers M, Rees VW, Hatsukami DK, Cummings KM, O'Connor RJ.

Am J Health Behav. 2016 Sep;40(5):652-8. doi: 10.5993/AJHB.40.5.12.

38.

Design and methods of the Population Assessment of Tobacco and Health (PATH) Study.

Hyland A, Ambrose BK, Conway KP, Borek N, Lambert E, Carusi C, Taylor K, Crosse S, Fong GT, Cummings KM, Abrams D, Pierce JP, Sargent J, Messer K, Bansal-Travers M, Niaura R, Vallone D, Hammond D, Hilmi N, Kwan J, Piesse A, Kalton G, Lohr S, Pharris-Ciurej N, Castleman V, Green VR, Tessman G, Kaufman A, Lawrence C, van Bemmel DM, Kimmel HL, Blount B, Yang L, O'Brien B, Tworek C, Alberding D, Hull LC, Cheng YC, Maklan D, Backinger CL, Compton WM.

Tob Control. 2017 Jul;26(4):371-378. doi: 10.1136/tobaccocontrol-2016-052934. Epub 2016 Aug 8.

39.

A longitudinal, naturalistic study of U.S. smokers' trial and adoption of snus.

Burris JL, Wahlquist AE, Alberg AJ, Cummings KM, Gray KM, Garrett-Mayer E, Carpenter MJ.

Addict Behav. 2016 Dec;63:82-8. doi: 10.1016/j.addbeh.2016.07.008. Epub 2016 Jul 15.

40.

Does Reactance against Cigarette Warning Labels Matter? Warning Label Responses and Downstream Smoking Cessation amongst Adult Smokers in Australia, Canada, Mexico and the United States.

Cho YJ, Thrasher JF, Swayampakala K, Yong HH, McKeever R, Hammond D, Anshari D, Cummings KM, Borland R.

PLoS One. 2016 Jul 13;11(7):e0159245. doi: 10.1371/journal.pone.0159245. eCollection 2016.

41.

Perceptions of "Natural" and "Additive-Free" Cigarettes and Intentions to Purchase.

O'Connor RJ, Lewis MJ, Adkison SE, Bansal-Travers M, Cummings KM.

Health Educ Behav. 2017 Apr;44(2):222-226. doi: 10.1177/1090198116653935. Epub 2016 Jul 9.

PMID:
27281493
42.

Prevalence and Correlates of the Belief That Electronic Cigarettes are a Lot Less Harmful Than Conventional Cigarettes Under the Different Regulatory Environments of Australia and the United Kingdom.

Yong HH, Borland R, Balmford J, Hitchman SC, Cummings KM, Driezen P, Thompson ME.

Nicotine Tob Res. 2017 Feb;19(2):258-263. doi: 10.1093/ntr/ntw137. Epub 2016 May 17.

43.

A framework for evaluating the public health impact of e-cigarettes and other vaporized nicotine products.

Levy DT, Cummings KM, Villanti AC, Niaura R, Abrams DB, Fong GT, Borland R.

Addiction. 2017 Jan;112(1):8-17. doi: 10.1111/add.13394. Epub 2016 Apr 25. Review.

44.

US Smokers' Beliefs, Experiences and Perceptions of Different Cigarette Variants Before and After the FSPTCA Ban on Misleading Descriptors Such as "Light," "Mild," or "Low".

Yong HH, Borland R, Cummings KM, Lindblom EN, Li L, Bansal-Travers M, O'Connor RJ, Elton-Marshall T, Thrasher JF, Hammond D, Thompson ME, Partos TR.

Nicotine Tob Res. 2016 Nov;18(11):2115-2123. doi: 10.1093/ntr/ntw107. Epub 2016 Apr 15.

45.

Snus undermines quit attempts but not abstinence: a randomised clinical trial among US smokers.

Carpenter MJ, Wahlquist AE, Burris JL, Gray KM, Garrett-Mayer E, Cummings KM, Alberg AJ.

Tob Control. 2017 Mar;26(2):202-209. doi: 10.1136/tobaccocontrol-2015-052783. Epub 2016 Apr 12.

46.

Persistence and amplitude of cigarette demand in relation to quit intentions and attempts.

O'Connor RJ, Heckman BW, Adkison SE, Rees VW, Hatsukami DK, Bickel WK, Cummings KM.

Psychopharmacology (Berl). 2016 Jun;233(12):2365-71. doi: 10.1007/s00213-016-4286-x. Epub 2016 Apr 6.

47.

Cigarette package inserts can promote efficacy beliefs and sustained smoking cessation attempts: A longitudinal assessment of an innovative policy in Canada.

Thrasher JF, Swayampakala K, Cummings KM, Hammond D, Anshari D, Krugman DM, Hardin JW.

Prev Med. 2016 Jul;88:59-65. doi: 10.1016/j.ypmed.2016.03.006. Epub 2016 Mar 10.

48.

The Association of Exposure to Point-of-Sale Tobacco Marketing with Quit Attempt and Quit Success: Results from a Prospective Study of Smokers in the United States.

Siahpush M, Shaikh RA, Smith D, Hyland A, Cummings KM, Kessler AS, Dodd MD, Carlson L, Meza J, Wakefield M.

Int J Environ Res Public Health. 2016 Feb 6;13(2):203. doi: 10.3390/ijerph13020203.

49.

Mexico SimSmoke: how changes in tobacco control policies would impact smoking prevalence and smoking attributable deaths in Mexico.

Fleischer NL, Thrasher JF, Reynales-Shigematsu LM, Cummings KM, Meza R, Zhang Y, Levy DT.

Glob Public Health. 2017 Jul;12(7):830-845. doi: 10.1080/17441692.2015.1123749. Epub 2016 Feb 2.

50.

Trends in market share of leading cigarette brands in the USA: national survey on drug use and health 2002-2013.

Sharma A, Fix BV, Delnevo C, Cummings KM, O'Connor RJ.

BMJ Open. 2016 Jan 29;6(1):e008813. doi: 10.1136/bmjopen-2015-008813.

Supplemental Content

Loading ...
Support Center